+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lisdexamfetamine"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Lisdexamfetamine is a medication used to treat attention-deficit/hyperactivity disorder (ADHD) and binge eating disorder (BED). It is a central nervous system (CNS) stimulant and is the active ingredient in the brand name drug Vyvanse. It works by increasing the amount of dopamine and norepinephrine in the brain, which helps to improve focus and reduce impulsivity. It is available in both immediate-release and extended-release formulations. Lisdexamfetamine is generally well-tolerated and has few side effects. Common side effects include headache, dry mouth, insomnia, and decreased appetite. It is important to note that lisdexamfetamine can be habit-forming and should be used with caution. The lisdexamfetamine market is a growing segment of the mental disorders drugs market. It is used to treat a variety of conditions, including ADHD and BED, and is becoming increasingly popular due to its effectiveness and low side effect profile. Some companies in the lisdexamfetamine market include Shire Pharmaceuticals, Impax Laboratories, and Teva Pharmaceuticals. Show Less Read more